SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 58 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $920,000 | -76.9% | 4,555,678 | -0.6% | 0.00% | – |
Q2 2019 | $3,986,000 | -61.7% | 4,581,296 | +2.0% | 0.00% | -100.0% |
Q1 2019 | $10,416,000 | +41.6% | 4,489,690 | +41.6% | 0.00% | 0.0% |
Q4 2018 | $7,357,000 | -84.1% | 3,171,015 | +1.6% | 0.00% | -80.0% |
Q3 2018 | $46,238,000 | -2.1% | 3,119,969 | +0.3% | 0.01% | 0.0% |
Q2 2018 | $47,239,000 | -19.1% | 3,109,860 | -0.0% | 0.01% | -28.6% |
Q1 2018 | $58,405,000 | +6.2% | 3,109,962 | +0.9% | 0.01% | +16.7% |
Q4 2017 | $54,990,000 | -17.0% | 3,080,835 | +0.0% | 0.01% | -25.0% |
Q3 2017 | $66,250,000 | – | 3,079,684 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 758,610 | $1,760,000 | 1.30% |
Wildcat Capital Management, LLC | 295,613 | $686,000 | 0.45% |
PFM Health Sciences, LP | 1,576,619 | $3,658,000 | 0.10% |
Cohen Capital Management, Inc. | 108,010 | $251,000 | 0.07% |
Partner Investment Management, L.P. | 15,283 | $35,000 | 0.04% |
CLOUGH CAPITAL PARTNERS L P | 136,228 | $316,000 | 0.04% |
Tower Research Capital LLC (TRC) | 12,183 | $29,000 | 0.00% |
Assenagon Asset Management S.A. | 69,931 | $162,000 | 0.00% |
Ballentine Partners, LLC | 16,700 | $39,000 | 0.00% |
A.R.T. Advisors, LLC | 10,206 | $24,000 | 0.00% |